-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BHfsUB8ZFpj0HWwCZ9nQSho0oYqT7V1tbV0lqwMdue7J4zvVKDJG/3fGA1S7zk7H hbLSgpnjk5OAVM4Bju6lBw== 0001086364-07-000076.txt : 20070917 0001086364-07-000076.hdr.sgml : 20070917 20070917131023 ACCESSION NUMBER: 0001086364-07-000076 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070917 DATE AS OF CHANGE: 20070917 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: China Medical Technologies, Inc. CENTRAL INDEX KEY: 0001326059 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81526 FILM NUMBER: 071119556 BUSINESS ADDRESS: STREET 1: NO.24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL CITY: DEVELOPMENT AREA, BEIJING STATE: F4 ZIP: 100176 BUSINESS PHONE: (86-10) 6787 1166 MAIL ADDRESS: STREET 1: NO.24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL CITY: DEVELOPMENT AREA, BEIJING STATE: F4 ZIP: 100176 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 40 EAST 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 40 EAST 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 chinamedicaltechamend.txt CHINA MEDICAL TECHNOLGIES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.: 1 )** CHINA MEDICAL TECHNOLOGIES, INC. - -------------------------------------------------------------------- (Name of Issuer) COMMON STOCK* - -------------------------------------------------------------------- (Title of Class of Securities) 169483104 - -------------------------------------------------------------------- (CUSIP NUMBER) August 31, 2007 - -------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: [X] Rule 13d-1 (b) [ ] Rule 13d-1 (c) [ ] Rule 13d-1 (d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ** This Amendment was filed to correct prior filing which overstated BlackRock's position in China Medical Technologies, Inc.. BlackRock's actual position is reported herein. Page 2 of 7 CUSIP No. 169483104 13G 1. NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) BlackRock, Inc. (on behalf of its investment advisory subsidiaries - See Item 7) 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP Joint Filing (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER NONE 6. SHARED VOTING POWER 2,982,000* 7. SOLE DISPOSITIVE POWER NONE 8. SHARED DISPOSITIVE POWER 2,982,000* 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,982,000* (ownership disclaimed pursuant to Rule 13d-4 of the 1934 Act) 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 1.09% 12. TYPE OF REPORTING PERSON HC, CO *Shares reported represent ordinary shares held through ADR's. Page 3 of 7 ITEM 1 (a) Name of Issuer: ---------------- CHINA MEDICAL TECHNOLOGIES INC. (the "Company") ITEM 1 (b) Address of Issuer's Principal Executive Offices: ------------------------------------------------- Beijing Economic - Technological Development Area Beijing, 100176 China ITEM 2 (a) Name of Person Filing: ------------------------ BlackRock, Inc. (on behalf of its investment advisory subsidiaries - See Item 7) ITEM 2 (b) Address of Principal Business Office or, if none, Residence: ------------------------------------------------------------- BlackRock, Inc. 40 East 52nd Street New York, NY 10022 ITEM 2 (c) Citizenship: ------------- See Item 4 of Cover Page ITEM 2 (d) Title of Class Securities: --------------------------- Common Stock ITEM 2 (e) CUSIP NUMBER: See Cover Page Page 4 of 7 ITEM 3 If this statement is filed pursuant to SS 240.13d-1(b) or 240.13d-2(b) OR (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C 78c), (b) [ ] Bank as defined in Section 3(a) (6) of the Act (15 U.S.C 78c), (c) [ ] Insurance Company as defined in Section 3(a) (19) of the Act (15 U.S.C 78c), (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8), (e) [X] Investment Adviser in accordance with SS 240. 13d-1(b) (1) (ii) (E), (f) [ ] Employee Benefit Plan or Endowment Fund in accordance with SS 240. 13d-1(b) (ii) (F), (g) [X] Parent Holding Company or Control Person in accordance with SS.SS.240. 13d-1(b) (ii) (G); see Item 7, (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813), (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c) (14) of the Investment Company Act of 1940(15 U.S.C 80a-3), (j) [ ] Group, in accordance with SS 240. 13d-1(b) (1) (ii) (J). ITEM 4 Ownership -------- (a) Amount Beneficially Owned: See Item 9 of Cover Page. (b) Percent of Class: See Item 11 of Cover Page (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: See Item 5 of Cover page (ii) shared power to vote or to direct the vote: See Item 6 of Cover page (iii) sole power to dispose or to direct the disposition of: See Item 7 of Cover page (iv) shared power to dispose or to direct the disposition of: See Item 8 of Cover page Page 5 of 7 ITEM 5 Ownership of Five Percent or Less of a Class. --------------------------------------------- If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ X ] ITEM 6 Ownership of More than Five Percent on Behalf of Another Person. ---------------------------------------------------------------- Not Applicable ITEM 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. -------------------------------------------------------------------- The following subsidiaries of BlackRock, Inc. are investment advisors which hold shares of the security being reported; BlackRock Advisors LLC BlackRock Capital Management, Inc. BlackRock Financial Management, Inc. ITEM 8 Identification and Classification of Members of the Group. ---------------------------------------------------------- Not Applicable ITEM 9 Notice of Dissolution of Group. ------------------------------- Not Applicable Page 6 of 7 ITEM 10 Certification -------------- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. Signature. - ---------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: September 17, 2007 BlackRock, Inc. (on behalf of its investment advisory subsidiaries) BlackRock Advisors LLC BlackRock Capital Management, Inc. BlackRock Financial Management, Inc. /s/ Denis Molleur - ----------------------------- Name: Denis Molleur Title: Attorney-In-Fact* - ----------------------------- *Signed pursuant to a power of attorney, dated October 4, 2006, included as Exhibit A to this Schedule 13G filed with the Securities and Exchange Commission by BlackRock, Inc. Page 7 of 7 EXHIBIT B POWER OF ATTORNEY The undersigned, BLACKROCK, INC., a corporation duly organized under the laws of the State of Delaware, on its behalf and that of its subsidiaries (collectively, the "Company"), does hereby make, constitute and appoint each of James DesMarais, Bartholomew Battista, Dan Waltcher, Vincent Tritto, Karen Clark, Denis Molleur, Alice Pellegrino and Jeffrey Hiller acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company is acting individually or as representative of others, any and all documents, certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Forms 3, 4,5,13D,13F and 13G and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall be valid from the date hereof and remain in full force and effect until either revoked in writing by the company, or, in respect if any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 4th day of October, 2006. BLACKROCK, Inc. By:_/s/ Ralph Schlosstein__________________________________ Name: Ralph Schlosstein Title: President Page 2 of 7 -----END PRIVACY-ENHANCED MESSAGE-----